Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo-Reference-Cited by-同舟云学术

Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo

Published:1990-04 Issue:4 Volume:33 Page:477-484
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Paulus Harold E.,Egger Marlene J.,Ward John R.,James Williams H.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference16 articles.

1. Traditional Assessments of Articular Diseases

2. Measuring Function and Health Status in Rheumatic Disease Clinical Trials

3. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical Trial

4. Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis

Cited by 257 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. John R. Ward, MD: Pioneer—Clinical Trials in Rheumatology;Rheumatic Disease Clinics of North America;2024-02

2. Determination of the most appropriate ACR response definition for contemporary drug approval trials in rheumatoid arthritis;Annals of the Rheumatic Diseases;2023-09-27

3. Composite measures to assess disease damage, disease severity and treatment response in systemic sclerosis clinical trials;Current Opinion in Rheumatology;2023-08-29

4. Measuring Disease Activity and Functional Capacity in Telerheumatology;Telerheumatology;2022

5. New composite endpoint in early diffuse cutaneous systemic sclerosis: revisiting the provisional American College of Rheumatology Composite Response Index in Systemic Sclerosis;Annals of the Rheumatic Diseases;2020-11-30